{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Nanomateriales%20Qu%C3%ADmicos%20Avanzados%2C%20S.A.%20de%20C.V.","name":"Nanomateriales Químicos Avanzados, S.A. de C.V.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-08T00:20:13.253Z"},"count":1,"matches":[{"id":"9e6efe5498a988ac","posted_date":"2021-09-21","letter_issue_date":"2021-09-15","company_name":"Nanomateriales Químicos Avanzados, S.A. de C.V.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/9e6efe5498a988ac"}]}